Literature DB >> 22945230

All for one, one for all: new combinatorial RNAi therapies combat hepatitis C virus evolution.

Dirk Grimm1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22945230      PMCID： PMC3437588          DOI： 10.1038/mt.2012.173

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  19 in total

1.  In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.

Authors:  Helen Lavender; Kevin Brady; Frances Burden; Oona Delpuech-Adams; Hubert Denise; Amy Palmer; Hannah Perkins; Boris Savic; Sarah Scott; Caroline Smith-Burchnell; Phil Troke; J Fraser Wright; David Suhy; Romu Corbau
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

2.  Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.

Authors:  Dominik Jarczak; Mortimer Korf; Carmela Beger; Michael P Manns; Martin Krüger
Journal:  FEBS J       Date:  2005-11       Impact factor: 5.542

3.  Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.

Authors:  Partha K Chandra; Anup K Kundu; Sidhartha Hazari; Sruti Chandra; Lili Bao; Tara Ooms; Gilbert F Morris; Tong Wu; Tarun K Mandal; Srikanta Dash
Journal:  Mol Ther       Date:  2012-05-22       Impact factor: 11.454

4.  Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.

Authors:  Xiao Yang; Virginia Haurigot; Shangzhen Zhou; Guangxiang Luo; Linda B Couto
Journal:  Hepatology       Date:  2010-10-07       Impact factor: 17.425

5.  Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver.

Authors:  Dirk Grimm; Lora Wang; Joyce S Lee; Nina Schürmann; Shuo Gu; Kathleen Börner; Theresa A Storm; Mark A Kay
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

6.  Optimization of linear double-stranded RNA for the production of multiple siRNAs targeting hepatitis C virus.

Authors:  Duckhyang Shin; Hyeon Lee; Soo In Kim; Yeup Yoon; Meehyein Kim
Journal:  RNA       Date:  2009-03-26       Impact factor: 4.942

7.  Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.

Authors:  Jan Krönke; Ralf Kittler; Frank Buchholz; Marc P Windisch; Thomas Pietschmann; Ralf Bartenschlager; Michael Frese
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.

Authors:  Mortimer Korf; Dominik Jarczak; Carmela Beger; Michael P Manns; Martin Krüger
Journal:  J Hepatol       Date:  2005-08       Impact factor: 25.083

Review 9.  New targets for antiviral therapy of chronic hepatitis C.

Authors:  Sandra Bühler; Ralf Bartenschlager
Journal:  Liver Int       Date:  2012-02       Impact factor: 5.828

10.  Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region.

Authors:  Joyce A Wilson; Christopher D Richardson
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103
View more
  4 in total

Review 1.  Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines.

Authors:  Jinho Park; Joonyoung Park; Yihua Pei; Jun Xu; Yoon Yeo
Journal:  Adv Drug Deliv Rev       Date:  2015-12-10       Impact factor: 15.470

Review 2.  Host-targeting agents in the treatment of hepatitis C: a beginning and an end?

Authors:  James M Baugh; Jose A Garcia-Rivera; Philippe A Gallay
Journal:  Antiviral Res       Date:  2013-09-30       Impact factor: 5.970

3.  Evolution of animal and plant dicers: early parallel duplications and recurrent adaptation of antiviral RNA binding in plants.

Authors:  Krishanu Mukherjee; Henry Campos; Bryan Kolaczkowski
Journal:  Mol Biol Evol       Date:  2012-11-22       Impact factor: 16.240

4.  Up-regulation of microRNA-203 in influenza A virus infection inhibits viral replication by targeting DR1.

Authors:  Sen Zhang; Jing Li; Junfeng Li; Yinhui Yang; Xiaoping Kang; Yuchang Li; Xiaoyan Wu; Qingyu Zhu; Yusen Zhou; Yi Hu
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.